Oncology Biomarker Market

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oncology Biomarker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Lung Cancer
        1.2.3 Breast Cancer
        1.2.4 Colorectal Cancer
        1.2.5 Prostate Cancer
        1.2.6 Stomach Cancer
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Oncology Biomarker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Diagnostics
        1.3.3 Drug Discovery And Development
        1.3.4 Prognostics
        1.3.5 Risk Assessment
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Oncology Biomarker Market Perspective (2017-2028)
    2.2 Oncology Biomarker Growth Trends by Region
        2.2.1 Oncology Biomarker Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Oncology Biomarker Historic Market Size by Region (2017-2022)
        2.2.3 Oncology Biomarker Forecasted Market Size by Region (2023-2028)
    2.3 Oncology Biomarker Market Dynamics
        2.3.1 Oncology Biomarker Industry Trends
        2.3.2 Oncology Biomarker Market Drivers
        2.3.3 Oncology Biomarker Market Challenges
        2.3.4 Oncology Biomarker Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Oncology Biomarker Players by Revenue
        3.1.1 Global Top Oncology Biomarker Players by Revenue (2017-2022)
        3.1.2 Global Oncology Biomarker Revenue Market Share by Players (2017-2022)
    3.2 Global Oncology Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Oncology Biomarker Revenue
    3.4 Global Oncology Biomarker Market Concentration Ratio
        3.4.1 Global Oncology Biomarker Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oncology Biomarker Revenue in 2021
    3.5 Oncology Biomarker Key Players Head office and Area Served
    3.6 Key Players Oncology Biomarker Product Solution and Service
    3.7 Date of Enter into Oncology Biomarker Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Biomarker Breakdown Data by Type
    4.1 Global Oncology Biomarker Historic Market Size by Type (2017-2022)
    4.2 Global Oncology Biomarker Forecasted Market Size by Type (2023-2028)
5 Oncology Biomarker Breakdown Data by Application
    5.1 Global Oncology Biomarker Historic Market Size by Application (2017-2022)
    5.2 Global Oncology Biomarker Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Oncology Biomarker Market Size (2017-2028)
    6.2 North America Oncology Biomarker Market Size by Type
        6.2.1 North America Oncology Biomarker Market Size by Type (2017-2022)
        6.2.2 North America Oncology Biomarker Market Size by Type (2023-2028)
        6.2.3 North America Oncology Biomarker Market Share by Type (2017-2028)
    6.3 North America Oncology Biomarker Market Size by Application
        6.3.1 North America Oncology Biomarker Market Size by Application (2017-2022)
        6.3.2 North America Oncology Biomarker Market Size by Application (2023-2028)
        6.3.3 North America Oncology Biomarker Market Share by Application (2017-2028)
    6.4 North America Oncology Biomarker Market Size by Country
        6.4.1 North America Oncology Biomarker Market Size by Country (2017-2022)
        6.4.2 North America Oncology Biomarker Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Oncology Biomarker Market Size (2017-2028)
    7.2 Europe Oncology Biomarker Market Size by Type
        7.2.1 Europe Oncology Biomarker Market Size by Type (2017-2022)
        7.2.2 Europe Oncology Biomarker Market Size by Type (2023-2028)
        7.2.3 Europe Oncology Biomarker Market Share by Type (2017-2028)
    7.3 Europe Oncology Biomarker Market Size by Application
        7.3.1 Europe Oncology Biomarker Market Size by Application (2017-2022)
        7.3.2 Europe Oncology Biomarker Market Size by Application (2023-2028)
        7.3.3 Europe Oncology Biomarker Market Share by Application (2017-2028)
    7.4 Europe Oncology Biomarker Market Size by Country
        7.4.1 Europe Oncology Biomarker Market Size by Country (2017-2022)
        7.4.2 Europe Oncology Biomarker Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Oncology Biomarker Market Size (2017-2028)
    8.2 Asia-Pacific Oncology Biomarker Market Size by Type
        8.2.1 Asia-Pacific Oncology Biomarker Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Oncology Biomarker Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Oncology Biomarker Market Share by Type (2017-2028)
    8.3 Asia-Pacific Oncology Biomarker Market Size by Application
        8.3.1 Asia-Pacific Oncology Biomarker Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Oncology Biomarker Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Oncology Biomarker Market Share by Application (2017-2028)
    8.4 Asia-Pacific Oncology Biomarker Market Size by Region
        8.4.1 Asia-Pacific Oncology Biomarker Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Oncology Biomarker Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Oncology Biomarker Market Size (2017-2028)
    9.2 Latin America Oncology Biomarker Market Size by Type
        9.2.1 Latin America Oncology Biomarker Market Size by Type (2017-2022)
        9.2.2 Latin America Oncology Biomarker Market Size by Type (2023-2028)
        9.2.3 Latin America Oncology Biomarker Market Share by Type (2017-2028)
    9.3 Latin America Oncology Biomarker Market Size by Application
        9.3.1 Latin America Oncology Biomarker Market Size by Application (2017-2022)
        9.3.2 Latin America Oncology Biomarker Market Size by Application (2023-2028)
        9.3.3 Latin America Oncology Biomarker Market Share by Application (2017-2028)
    9.4 Latin America Oncology Biomarker Market Size by Country
        9.4.1 Latin America Oncology Biomarker Market Size by Country (2017-2022)
        9.4.2 Latin America Oncology Biomarker Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Oncology Biomarker Market Size (2017-2028)
    10.2 Middle East & Africa Oncology Biomarker Market Size by Type
        10.2.1 Middle East & Africa Oncology Biomarker Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Oncology Biomarker Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Oncology Biomarker Market Share by Type (2017-2028)
    10.3 Middle East & Africa Oncology Biomarker Market Size by Application
        10.3.1 Middle East & Africa Oncology Biomarker Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Oncology Biomarker Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Oncology Biomarker Market Share by Application (2017-2028)
    10.4 Middle East & Africa Oncology Biomarker Market Size by Country
        10.4.1 Middle East & Africa Oncology Biomarker Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Oncology Biomarker Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Oncology Biomarker Introduction
        11.1.4 Abbott Laboratories Revenue in Oncology Biomarker Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Developments
    11.2 Bristol-Myers Squibb
        11.2.1 Bristol-Myers Squibb Company Details
        11.2.2 Bristol-Myers Squibb Business Overview
        11.2.3 Bristol-Myers Squibb Oncology Biomarker Introduction
        11.2.4 Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2017-2022)
        11.2.5 Bristol-Myers Squibb Recent Developments
    11.3 Eli Lilly and Company
        11.3.1 Eli Lilly and Company Company Details
        11.3.2 Eli Lilly and Company Business Overview
        11.3.3 Eli Lilly and Company Oncology Biomarker Introduction
        11.3.4 Eli Lilly and Company Revenue in Oncology Biomarker Business (2017-2022)
        11.3.5 Eli Lilly and Company Recent Developments
    11.4 F.Hoffmann-La Roche Ltd.
        11.4.1 F.Hoffmann-La Roche Ltd. Company Details
        11.4.2 F.Hoffmann-La Roche Ltd. Business Overview
        11.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Introduction
        11.4.4 F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2017-2022)
        11.4.5 F.Hoffmann-La Roche Ltd. Recent Developments
    11.5 Genomic Health
        11.5.1 Genomic Health Company Details
        11.5.2 Genomic Health Business Overview
        11.5.3 Genomic Health Oncology Biomarker Introduction
        11.5.4 Genomic Health Revenue in Oncology Biomarker Business (2017-2022)
        11.5.5 Genomic Health Recent Developments
    11.6 GlaxoSmithKline plc
        11.6.1 GlaxoSmithKline plc Company Details
        11.6.2 GlaxoSmithKline plc Business Overview
        11.6.3 GlaxoSmithKline plc Oncology Biomarker Introduction
        11.6.4 GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2017-2022)
        11.6.5 GlaxoSmithKline plc Recent Developments
    11.7 Novartis AG
        11.7.1 Novartis AG Company Details
        11.7.2 Novartis AG Business Overview
        11.7.3 Novartis AG Oncology Biomarker Introduction
        11.7.4 Novartis AG Revenue in Oncology Biomarker Business (2017-2022)
        11.7.5 Novartis AG Recent Developments
    11.8 Merck & Co.
        11.8.1 Merck & Co. Company Details
        11.8.2 Merck & Co. Business Overview
        11.8.3 Merck & Co. Oncology Biomarker Introduction
        11.8.4 Merck & Co. Revenue in Oncology Biomarker Business (2017-2022)
        11.8.5 Merck & Co. Recent Developments
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Oncology Biomarker Introduction
        11.9.4 Pfizer Revenue in Oncology Biomarker Business (2017-2022)
        11.9.5 Pfizer Recent Developments
    11.10 Qiagen N.V.
        11.10.1 Qiagen N.V. Company Details
        11.10.2 Qiagen N.V. Business Overview
        11.10.3 Qiagen N.V. Oncology Biomarker Introduction
        11.10.4 Qiagen N.V. Revenue in Oncology Biomarker Business (2017-2022)
        11.10.5 Qiagen N.V. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Oncology Biomarker Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Lung Cancer
    Table 3. Key Players of Breast Cancer
    Table 4. Key Players of Colorectal Cancer
    Table 5. Key Players of Prostate Cancer
    Table 6. Key Players of Stomach Cancer
    Table 7. Key Players of Others
    Table 8. Global Oncology Biomarker Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 9. Global Oncology Biomarker Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Oncology Biomarker Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Oncology Biomarker Market Share by Region (2017-2022)
    Table 12. Global Oncology Biomarker Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Oncology Biomarker Market Share by Region (2023-2028)
    Table 14. Oncology Biomarker Market Trends
    Table 15. Oncology Biomarker Market Drivers
    Table 16. Oncology Biomarker Market Challenges
    Table 17. Oncology Biomarker Market Restraints
    Table 18. Global Oncology Biomarker Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Oncology Biomarker Revenue Share by Players (2017-2022)
    Table 20. Global Top Oncology Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Biomarker as of 2021)
    Table 21. Ranking of Global Top Oncology Biomarker Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Oncology Biomarker Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Oncology Biomarker Product Solution and Service
    Table 25. Date of Enter into Oncology Biomarker Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Oncology Biomarker Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Oncology Biomarker Revenue Market Share by Type (2017-2022)
    Table 29. Global Oncology Biomarker Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Oncology Biomarker Revenue Market Share by Type (2023-2028)
    Table 31. Global Oncology Biomarker Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Oncology Biomarker Revenue Share by Application (2017-2022)
    Table 33. Global Oncology Biomarker Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Oncology Biomarker Revenue Share by Application (2023-2028)
    Table 35. North America Oncology Biomarker Market Size by Type (2017-2022) & (US$ Million)
    Table 36. North America Oncology Biomarker Market Size by Type (2023-2028) & (US$ Million)
    Table 37. North America Oncology Biomarker Market Size by Application (2017-2022) & (US$ Million)
    Table 38. North America Oncology Biomarker Market Size by Application (2023-2028) & (US$ Million)
    Table 39. North America Oncology Biomarker Market Size by Country (2017-2022) & (US$ Million)
    Table 40. North America Oncology Biomarker Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Europe Oncology Biomarker Market Size by Type (2017-2022) & (US$ Million)
    Table 42. Europe Oncology Biomarker Market Size by Type (2023-2028) & (US$ Million)
    Table 43. Europe Oncology Biomarker Market Size by Application (2017-2022) & (US$ Million)
    Table 44. Europe Oncology Biomarker Market Size by Application (2023-2028) & (US$ Million)
    Table 45. Europe Oncology Biomarker Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Europe Oncology Biomarker Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Oncology Biomarker Market Size by Type (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Oncology Biomarker Market Size by Type (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Oncology Biomarker Market Size by Application (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Oncology Biomarker Market Size by Application (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Oncology Biomarker Market Size by Region (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Oncology Biomarker Market Size by Region (2023-2028) & (US$ Million)
    Table 53. Latin America Oncology Biomarker Market Size by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Oncology Biomarker Market Size by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Oncology Biomarker Market Size by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Oncology Biomarker Market Size by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Oncology Biomarker Market Size by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Oncology Biomarker Market Size by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Oncology Biomarker Market Size by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Oncology Biomarker Market Size by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Oncology Biomarker Market Size by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Oncology Biomarker Market Size by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Oncology Biomarker Market Size by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Oncology Biomarker Market Size by Country (2023-2028) & (US$ Million)
    Table 65. Abbott Laboratories Company Details
    Table 66. Abbott Laboratories Business Overview
    Table 67. Abbott Laboratories Oncology Biomarker Product
    Table 68. Abbott Laboratories Revenue in Oncology Biomarker Business (2017-2022) & (US$ Million)
    Table 69. Abbott Laboratories Recent Developments
    Table 70. Bristol-Myers Squibb Company Details
    Table 71. Bristol-Myers Squibb Business Overview
    Table 72. Bristol-Myers Squibb Oncology Biomarker Product
    Table 73. Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2017-2022) & (US$ Million)
    Table 74. Bristol-Myers Squibb Recent Developments
    Table 75. Eli Lilly and Company Company Details
    Table 76. Eli Lilly and Company Business Overview
    Table 77. Eli Lilly and Company Oncology Biomarker Product
    Table 78. Eli Lilly and Company Revenue in Oncology Biomarker Business (2017-2022) & (US$ Million)
    Table 79. Eli Lilly and Company Recent Developments
    Table 80. F.Hoffmann-La Roche Ltd. Company Details
    Table 81. F.Hoffmann-La Roche Ltd. Business Overview
    Table 82. F.Hoffmann-La Roche Ltd. Oncology Biomarker Product
    Table 83. F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2017-2022) & (US$ Million)
    Table 84. F.Hoffmann-La Roche Ltd. Recent Developments
    Table 85. Genomic Health Company Details
    Table 86. Genomic Health Business Overview
    Table 87. Genomic Health Oncology Biomarker Product
    Table 88. Genomic Health Revenue in Oncology Biomarker Business (2017-2022) & (US$ Million)
    Table 89. Genomic Health Recent Developments
    Table 90. GlaxoSmithKline plc Company Details
    Table 91. GlaxoSmithKline plc Business Overview
    Table 92. GlaxoSmithKline plc Oncology Biomarker Product
    Table 93. GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2017-2022) & (US$ Million)
    Table 94. GlaxoSmithKline plc Recent Developments
    Table 95. Novartis AG Company Details
    Table 96. Novartis AG Business Overview
    Table 97. Novartis AG Oncology Biomarker Product
    Table 98. Novartis AG Revenue in Oncology Biomarker Business (2017-2022) & (US$ Million)
    Table 99. Novartis AG Recent Developments
    Table 100. Merck & Co. Company Details
    Table 101. Merck & Co. Business Overview
    Table 102. Merck & Co. Oncology Biomarker Product
    Table 103. Merck & Co. Revenue in Oncology Biomarker Business (2017-2022) & (US$ Million)
    Table 104. Merck & Co. Recent Developments
    Table 105. Pfizer Company Details
    Table 106. Pfizer Business Overview
    Table 107. Pfizer Oncology Biomarker Product
    Table 108. Pfizer Revenue in Oncology Biomarker Business (2017-2022) & (US$ Million)
    Table 109. Pfizer Recent Developments
    Table 110. Qiagen N.V. Company Details
    Table 111. Qiagen N.V. Business Overview
    Table 112. Qiagen N.V. Oncology Biomarker Product
    Table 113. Qiagen N.V. Revenue in Oncology Biomarker Business (2017-2022) & (US$ Million)
    Table 114. Qiagen N.V. Recent Developments
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncology Biomarker Market Share by Type: 2021 VS 2028
    Figure 2. Lung Cancer Features
    Figure 3. Breast Cancer Features
    Figure 4. Colorectal Cancer Features
    Figure 5. Prostate Cancer Features
    Figure 6. Stomach Cancer Features
    Figure 7. Others Features
    Figure 8. Global Oncology Biomarker Market Share by Application: 2021 VS 2028
    Figure 9. Diagnostics Case Studies
    Figure 10. Drug Discovery And Development Case Studies
    Figure 11. Prognostics Case Studies
    Figure 12. Risk Assessment Case Studies
    Figure 13. Others Case Studies
    Figure 14. Oncology Biomarker Report Years Considered
    Figure 15. Global Oncology Biomarker Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Oncology Biomarker Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Oncology Biomarker Market Share by Region: 2021 VS 2028
    Figure 18. Global Oncology Biomarker Market Share by Players in 2021
    Figure 19. Global Top Oncology Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Biomarker as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Oncology Biomarker Revenue in 2021
    Figure 21. North America Oncology Biomarker Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. North America Oncology Biomarker Market Size Market Share by Type (2017-2028)
    Figure 23. North America Oncology Biomarker Market Size Market Share by Application (2017-2028)
    Figure 24. North America Oncology Biomarker Market Size Share by Country (2017-2028)
    Figure 25. United States Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Canada Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Oncology Biomarker Market Size YoY (2017-2028) & (US$ Million)
    Figure 28. Europe Oncology Biomarker Market Size Market Share by Type (2017-2028)
    Figure 29. Europe Oncology Biomarker Market Size Market Share by Application (2017-2028)
    Figure 30. Europe Oncology Biomarker Market Size Share by Country (2017-2028)
    Figure 31. Germany Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. France Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. U.K. Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Italy Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Russia Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Nordic Countries Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Oncology Biomarker Market Size YoY (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific Oncology Biomarker Market Size Market Share by Type (2017-2028)
    Figure 39. Asia Pacific Oncology Biomarker Market Size Market Share by Application (2017-2028)
    Figure 40. Asia Pacific Oncology Biomarker Market Size Share by Region (2017-2028)
    Figure 41. China Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Japan Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. South Korea Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Southeast Asia Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. India Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Australia Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 47. Latin America Oncology Biomarker Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Latin America Oncology Biomarker Market Size Market Share by Type (2017-2028)
    Figure 49. Latin America Oncology Biomarker Market Size Market Share by Application (2017-2028)
    Figure 50. Latin America Oncology Biomarker Market Size Share by Country (2017-2028)
    Figure 51. Mexico Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Brazil Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Oncology Biomarker Market Size YoY (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa Oncology Biomarker Market Size Market Share by Type (2017-2028)
    Figure 55. Middle East and Africa Oncology Biomarker Market Size Market Share by Application (2017-2028)
    Figure 56. Middle East and Africa Oncology Biomarker Market Size Share by Country (2017-2028)
    Figure 57. Turkey Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. UAE Oncology Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Abbott Laboratories Revenue Growth Rate in Oncology Biomarker Business (2017-2022)
    Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Oncology Biomarker Business (2017-2022)
    Figure 62. Eli Lilly and Company Revenue Growth Rate in Oncology Biomarker Business (2017-2022)
    Figure 63. F.Hoffmann-La Roche Ltd. Revenue Growth Rate in Oncology Biomarker Business (2017-2022)
    Figure 64. Genomic Health Revenue Growth Rate in Oncology Biomarker Business (2017-2022)
    Figure 65. GlaxoSmithKline plc Revenue Growth Rate in Oncology Biomarker Business (2017-2022)
    Figure 66. Novartis AG Revenue Growth Rate in Oncology Biomarker Business (2017-2022)
    Figure 67. Merck & Co. Revenue Growth Rate in Oncology Biomarker Business (2017-2022)
    Figure 68. Pfizer Revenue Growth Rate in Oncology Biomarker Business (2017-2022)
    Figure 69. Qiagen N.V. Revenue Growth Rate in Oncology Biomarker Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed